無針注射器の世界市場:医療機器パイプライン分析

【英語タイトル】Needle Free Injections - Medical Devices Pipeline Assessment, 2019

GlobalDataが出版した調査資料(GDATA906125)・商品コード:GDATA906125
・発行会社(調査会社):GlobalData
・発行日:2019年5月8日
・ページ数:161
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Site LicenseUSD5,000 ⇒換算¥520,000見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD7,500 ⇒換算¥780,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Needle Free Injections – Medical Devices Pipeline Assessment, 2019
Summary

GlobalData’s Medical Devices sector report, “Needle Free Injections – Medical Devices Pipeline Assessment, 2019″ provides an overview of Needle Free Injections currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Needle Free Injections pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Needle Free Injections under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Needle Free Injections and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry.

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Needle Free Injections under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date.

【レポートの目次】

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Needle Free Injections Overview
3 Products under Development
3.1 Needle Free Injections – Pipeline Products by Stage of Development
3.2 Needle Free Injections – Pipeline Products by Territory
3.3 Needle Free Injections – Pipeline Products by Regulatory Path
3.4 Needle Free Injections – Pipeline Products by Estimated Approval Date
3.5 Needle Free Injections – Ongoing Clinical Trials
4 Needle Free Injections – Pipeline Products under Development by Companies
4.1 Needle Free Injections Companies – Pipeline Products by Stage of Development
4.2 Needle Free Injections – Pipeline Products by Stage of Development
5 Needle Free Injections Companies and Product Overview
5.1 B. Braun Melsungen AG Company Overview
5.2 Boston Scientific Corp Company Overview
5.3 Crossject SA Company Overview
5.4 Enable Injections Inc Company Overview
5.5 Enesi Pharma Ltd Company Overview
5.6 Eternity Healthcare Inc. Company Overview
5.7 Inovio Pharmaceuticals Inc Company Overview
5.8 Medical International Technologies (Mit Canada) Inc Company Overview
5.9 PharmaJet Inc Company Overview
5.10 Queen’s University Company Overview
5.11 Takeda Pharmaceutical Co Ltd Company Overview
5.12 Teva Pharmaceutical Industries Ltd Company Overview
6 Needle Free Injections- Recent Developments
6.1 May 02, 2019: Antares Pharma reports first quarter 2019 operating and financial results
6.2 May 02, 2019: Teva reports first quarter 2019 financial results
6.3 Apr 30, 2019: Merck announces first-quarter 2019 financial results
6.4 Apr 25, 2019: Baxter reports first-quarter 2019 results
6.5 Apr 24, 2019: Boston Scientific announces results for first quarter 2019
6.6 Apr 10, 2019: Enesi Pharma’s ImplaVax platform shortlisted for Best New Vaccine Technology/Platform at the Vaccine Industry Excellence (ViE) Awards 2019
6.7 Apr 10, 2019: Teva signs new $2.3 billion syndicated revolving credit facility
6.8 Mar 29, 2019: Daiichi Sankyo announces chief executive officer (CEO) change
6.9 Mar 05, 2019: Valeritas announces fourth quarter and full year 2018 financial results
6.10 Mar 04, 2019: Antares Pharma announces board changes
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

1.1 List of Tables
Table 1: Needle Free Injections - Pipeline Products by Stage of Development
Table 2: Needle Free Injections - Pipeline Products by Territory
Table 3: Needle Free Injections - Pipeline Products by Regulatory Path
Table 4: Needle Free Injections - Pipeline Products by Estimated Approval Date
Table 5: Needle Free Injections - Ongoing Clinical Trials
Table 6: Needle Free Injections Companies - Pipeline Products by Stage of Development
Table 7: Needle Free Injections - Pipeline Products by Stage of Development
Table 8: B. Braun Melsungen AG Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Needle-Free System - Product Status
Table 10: Needle-Free System - Product Description
Table 11: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 12: JetTouch System - Overactive Bladder - Product Status
Table 13: JetTouch System - Overactive Bladder - Product Description
Table 14: Crossject SA Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Zeneo ID Human Needle-Free Injection Device - Product Status
Table 16: Zeneo ID Human Needle-Free Injection Device - Product Description
Table 17: Zeneo IM 0.5ml Needle - Free Injection Device - Product Status
Table 18: Zeneo IM 0.5ml Needle - Free Injection Device - Product Description
Table 19: Zeneo SC 0.5ml Needle-Free Injection Device - Product Status
Table 20: Zeneo SC 0.5ml Needle-Free Injection Device - Product Description
Table 21: Zeneo SC 0.8ml Needle-Free Injection Device - Product Status
Table 22: Zeneo SC 0.8ml Needle-Free Injection Device - Product Description
Table 23: Zeneo SC High Viscosity Needle-Free Injection Device - Product Status
Table 24: Zeneo SC High Viscosity Needle-Free Injection Device - Product Description
Table 25: Enable Injections Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 26: Enable Smart enFuse - Product Status
Table 27: Enable Smart enFuse - Product Description
Table 28: Enable Injections Inc - Ongoing Clinical Trials Overview
Table 29: Enable Smart enFuse - Comparison of Two Infusion Devices with Respect to Pharmacokinetics, Safety and Tolerability of Hizentra: Investigational Wearable Infusor and the Crono S-pid-50 Infusion Pump
Table 30: Enesi Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 31: ImplaVax Device - Product Status
Table 32: ImplaVax Device - Product Description
Table 33: Eternity Healthcare Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Multi Channel Needle-Free Injection Device - Product Status
Table 35: Multi Channel Needle-Free Injection Device - Product Description
Table 36: Inovio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Intradermal Pen Injector - Product Status
Table 38: Intradermal Pen Injector - Product Description
Table 39: Intradermal Syringe - Product Status
Table 40: Intradermal Syringe - Product Description
Table 41: Mega Jet - Product Status
Table 42: Mega Jet - Product Description
Table 43: Multi-Port Orifices - Product Status
Table 44: Multi-Port Orifices - Product Description
Table 45: Needle-Free Vaccine Delivery Device - Product Status
Table 46: Needle-Free Vaccine Delivery Device - Product Description
Table 47: Medical International Technologies (Mit Canada) Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 48: MED-JET MBX Injector - Product Status
Table 49: MED-JET MBX Injector - Product Description
Table 50: MIT-H-III - Product Status
Table 51: MIT-H-III - Product Description
Table 52: MIT-H-IV-1 - Product Status
Table 53: MIT-H-IV-1 - Product Description
Table 54: MIT-H-IV-5 - Product Status
Table 55: MIT-H-IV-5 - Product Description
Table 56: MIT-H-VI Dental Injector - Product Status
Table 57: MIT-H-VI Dental Injector - Product Description
Table 58: PharmaJet Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Pre-filled Syringe - Product Status
Table 60: Pre-filled Syringe - Product Description
Table 61: Tropis - Product Status
Table 62: Tropis - Product Description

1.2 List of Figures
Figure 1: Needle Free Injections - Pipeline Products by Stage of Development
Figure 2: Needle Free Injections - Pipeline Products by Territory
Figure 3: Needle Free Injections - Pipeline Products by Regulatory Path
Figure 4: Needle Free Injections - Pipeline Products by Estimated Approval Date
Figure 5: Needle Free Injections - Ongoing Clinical Trials

【掲載企業】

B. Braun Melsungen AG
Boston Scientific Corp
Crossject SA
Enable Injections Inc
Enesi Pharma Ltd
Eternity Healthcare Inc.
Inovio Pharmaceuticals Inc
Medical International Technologies (Mit Canada) Inc
PharmaJet Inc
Queen's University
Takeda Pharmaceutical Co Ltd
Teva Pharmaceutical Industries Ltd

★調査レポート[無針注射器の世界市場:医療機器パイプライン分析] (コード:GDATA906125)販売に関する免責事項を必ずご確認ください。
★調査レポート[無針注射器の世界市場:医療機器パイプライン分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆